Health Canada has approved weight-loss drug Zepbound for treating obstructive sleep apnea in adults with obesity.The department confirmed that the authorization granted on June 11 makes Zepbound the only GLP-1 drug in Canada approved for the sleep disorder that causes people to stop breathing tempor...
Liking and disliking news Highlights will help Daily News Highlights to understand visitor interests and top trends as per the user behavior hence this feature requires visitor to Sign In, if you are not registered yet, please Sing Up to personalize your reading.